Impact of visceral fat distribution on postoperative complications in high-aged patients undergoing gastric cancer surgery: A cross-sectional study

Table 2 Comparison of the baseline characteristics of patients, n (%)

Item	Without complication	With complication	t/χ2	P value
Age	68.23 ± 7.94	69.12 ± 7.45	-0.892	0.419
Sex
Male	92 (65.2)	15 (68.2)	0.073	0.788
Female	49 (34.8)	7 (31.8)
BMI (kg/m2)	25.87 ± 5.19	29.14 ± 3.28	8.091	0.000
Combined hypertension
Yes	34 (24.1)	5 (22.7)	0.020	0.887
No	107 (75.9)	17 (77.3)
Combined diabetes
Yes	21 (14.9)	9 (42.9)	9.472	0.002
No	120 (85.1)	12 (57.1)
Combined hyperlipidemia
Yes	16 (11.3)	6 (27.3)	4.134	0.042
No	125 (88.7)	16 (72.7)
ASA score
I	61 (43.3)	3 (13.6)	7.004	0.008
II	80 (56.7)	19 (86.4)
Primary tumor site
Esophagogastric junction	55 (39.0)	9 (40.9)	0.123	0.940
Proximal stomach	49 (34.8)	8 (36.4)
Distal stomach	37 (26.2)	5 (22.7)
TNM stage
I stage	38 (27.0)	5 (22.7)	0.175	0.676
II stage	103 (73.0)	17 (77.3)
VFA	105.28 ± 37.61	151.98 ± 45.33	5.872	0.000
SFA	213.60 ± 57.18	247.35 ± 79.35	2.523	0.013
TFA	318.88 ± 47.40	399.33 ± 62.34	9.108	0.000
VSR	0.79 ± 0.41	1.07 ± 0.56	6.129	0.000

BMI: Body mass index; ASA: American Society of Anesthesiologists; VFA: Visceral fat area; SFA: Subcutaneous fat area; TFA: Total fat area; VSR: Visceral to subcutaneous fat area ratio; TNM: Tumor-node-metastasis.